Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer
Clinical trial NCT03253068 · UNKNOWN
Trial details
- NCT number
- NCT03253068
- Sponsor
- Wakayama Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2020-12-28
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.